JP7583438B2 - Ｈｃｎ１アンタゴニストとしての置換アルキルフェノール - Google Patents

Ｈｃｎ１アンタゴニストとしての置換アルキルフェノール Download PDF

Info

Publication number
JP7583438B2
JP7583438B2 JP2020573346A JP2020573346A JP7583438B2 JP 7583438 B2 JP7583438 B2 JP 7583438B2 JP 2020573346 A JP2020573346 A JP 2020573346A JP 2020573346 A JP2020573346 A JP 2020573346A JP 7583438 B2 JP7583438 B2 JP 7583438B2
Authority
JP
Japan
Prior art keywords
alkyl
substituted
unsubstituted
certain embodiments
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020573346A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020006224A5 (https=
JP2021529778A5 (https=
JP2021529778A (ja
Inventor
ティッブス，ガレス，アール．
ゴルドスタイン，ペーター
ソーブ，アンソニー，エー．
アプレティ，ラジェンドラ
ジュニア ワレン，ジェームズ，デイビッド
ジョイス，レベッカ，エル．
バールマン，ディプティ，エヌ．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell University
Original Assignee
Cornell University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell University filed Critical Cornell University
Publication of JP2021529778A publication Critical patent/JP2021529778A/ja
Publication of JPWO2020006224A5 publication Critical patent/JPWO2020006224A5/ja
Publication of JP2021529778A5 publication Critical patent/JP2021529778A5/ja
Application granted granted Critical
Publication of JP7583438B2 publication Critical patent/JP7583438B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/825—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups all hydroxy groups bound to the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2020573346A 2018-06-27 2019-06-27 Ｈｃｎ１アンタゴニストとしての置換アルキルフェノール Active JP7583438B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862690778P 2018-06-27 2018-06-27
US62/690,778 2018-06-27
US201962803109P 2019-02-08 2019-02-08
US62/803,109 2019-02-08
PCT/US2019/039493 WO2020006224A1 (en) 2018-06-27 2019-06-27 Substituted alkylphenols as hcn1 antagonists

Publications (4)

Publication Number Publication Date
JP2021529778A JP2021529778A (ja) 2021-11-04
JPWO2020006224A5 JPWO2020006224A5 (https=) 2022-06-29
JP2021529778A5 JP2021529778A5 (https=) 2022-06-29
JP7583438B2 true JP7583438B2 (ja) 2024-11-14

Family

ID=67297385

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020573346A Active JP7583438B2 (ja) 2018-06-27 2019-06-27 Ｈｃｎ１アンタゴニストとしての置換アルキルフェノール

Country Status (7)

Country Link
US (2) US11684590B2 (https=)
EP (1) EP3813948A1 (https=)
JP (1) JP7583438B2 (https=)
CN (1) CN113226468B (https=)
AU (1) AU2019294819B2 (https=)
CA (1) CA3145096A1 (https=)
WO (1) WO2020006224A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019294819B2 (en) * 2018-06-27 2025-04-03 Cornell University Substituted alkylphenols as HCN1 antagonists
WO2024143404A1 (ja) * 2022-12-26 2024-07-04 ダイキン工業株式会社 アルキレン鎖含有シラン化合物
CN117326999B (zh) * 2023-09-12 2025-11-18 辽宁靖帆新材料有限公司 一种二苯基[4-(苯硫基)苯基]全氟丁基磺酸锍盐的合成方法
CN117263796A (zh) * 2023-09-22 2023-12-22 安徽昊帆生物有限公司 十八烷二酸单叔丁酯的制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008530033A (ja) 2005-02-09 2008-08-07 ニューロメッド ファーマシューティカルズ リミテッド ジアミンカルシウムチャネルブロッカー
JP2008233249A (ja) 2007-03-16 2008-10-02 Fuji Xerox Co Ltd 静電荷像現像用トナー、静電荷像現像用現像剤及び画像形成装置
WO2011019747A1 (en) 2009-08-11 2011-02-17 The Trustees Of Columbia University In The City Of New York Compositions and methods of treating chronic pain by administering propofol derivatives
JP2014091696A (ja) 2012-11-02 2014-05-19 Dic Corp ビスフェノール誘導体
JP2018516270A (ja) 2015-06-04 2018-06-21 シェブロン・オロナイト・カンパニー・エルエルシー 高められた性能を有するヒンダードフェノール酸化防止剤／摩擦調整剤のホウ酸化ポリオールエステル

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1811322A1 (de) * 1968-11-28 1970-06-25 Merck Ag E Stabilisatoren
EP0303894A3 (en) 1987-08-18 1991-03-20 American Cyanamid Company Radiation sterilizable composition and articles made therefrom
US4820755A (en) 1987-08-18 1989-04-11 American Cyanamid Company Radiation sterilizable composition and articles made therefrom
JP2754039B2 (ja) * 1988-06-24 1998-05-20 塩野義製薬株式会社 ジ―ｔｅｒｔ―ブチルヒドロキシフェニルチオ誘導体
ATE161717T1 (de) * 1989-07-14 1998-01-15 Biodor Us Holding Corp Antivirale mittel
JPH03149287A (ja) * 1989-11-06 1991-06-25 Eisai Co Ltd フェノール誘導体
US5126487A (en) 1991-03-26 1992-06-30 The Procter & Gamble Company Process for the preparation of 2-alkyl-4-acyl-6-tert-butylphenol compounds
AU5833494A (en) 1992-12-22 1994-07-19 Smithkline Beecham Plc Piperidine derivatives as calcium channel antagonists
EP0761652A1 (en) 1995-08-01 1997-03-12 Mochida Pharmaceutical Co., Ltd. Acridinium compound having a plurality of luminescent groups and binding groups, and conjugate thereof
US6218437B1 (en) 1996-09-30 2001-04-17 The Regents Of The University Of California Treatment and prevention of hepatic disorders
JPH10195258A (ja) 1997-01-08 1998-07-28 Asahi Denka Kogyo Kk 農業用フィルム組成物
JP2003231777A (ja) 2002-02-07 2003-08-19 Mitsui Chemicals Inc 農業フィルム用ポリオレフィン樹脂組成物および農業用フィルム
AU2005249410A1 (en) 2004-05-14 2005-12-15 Emisphere Technologies, Inc. Aryl ketone compounds and compositions for delivering active agents
WO2007054446A1 (en) 2005-11-09 2007-05-18 Ciba Holding Inc. Photolatent systems
JPWO2011001974A1 (ja) * 2009-07-01 2012-12-13 Jx日鉱日石金属株式会社 Ｃｕ−Ｇａターゲット及びその製造方法
CN102382037B (zh) 2010-09-03 2016-01-20 中国医学科学院药物研究所 苯丙酸类化合物及其制法和药物用途
WO2013024040A2 (en) 2011-08-12 2013-02-21 B.S.R.C. Alexander Fleming Tnf superfamily trimerization inhibitors
WO2014101237A1 (zh) 2012-12-31 2014-07-03 深圳诺普信农化股份有限公司 抗光解农药及其应用
KR20170003527A (ko) 2014-02-24 2017-01-09 유리젠 파마슈티컬스, 인코포레이티드 경구 투여용 펜토산 폴리설페이트 염의 조성물
AU2019294819B2 (en) * 2018-06-27 2025-04-03 Cornell University Substituted alkylphenols as HCN1 antagonists

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008530033A (ja) 2005-02-09 2008-08-07 ニューロメッド ファーマシューティカルズ リミテッド ジアミンカルシウムチャネルブロッカー
JP2008233249A (ja) 2007-03-16 2008-10-02 Fuji Xerox Co Ltd 静電荷像現像用トナー、静電荷像現像用現像剤及び画像形成装置
WO2011019747A1 (en) 2009-08-11 2011-02-17 The Trustees Of Columbia University In The City Of New York Compositions and methods of treating chronic pain by administering propofol derivatives
JP2014091696A (ja) 2012-11-02 2014-05-19 Dic Corp ビスフェノール誘導体
JP2018516270A (ja) 2015-06-04 2018-06-21 シェブロン・オロナイト・カンパニー・エルエルシー 高められた性能を有するヒンダードフェノール酸化防止剤／摩擦調整剤のホウ酸化ポリオールエステル

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Amin MANTEGHI et al.，Polyolefin elastomer grafted unsaturated hindered phenol esters: synthesis and antioxidant behavior，Designed Monomers and Polymers，2016年05月23日，Vol. 19, No. 6，pp. 569-576
CAMILLE G. WERMUTH，Ｐａｒｔ ＩＶ 置換基と官能基：定性的，定量的構造活性相関，最新 創薬化学 上巻 THE PRACTICE OF MEDICINAL CHEMISTRY ，第1版，大塚 賢一郎 株式会社テクノミック
Stefano MENICHETTI et al.，Ethylene-based copolymers with tunable content of polymerizable hindered phenols as nonreleasing macromolecular additives，Journal of Polymer Science Part A: Polymer Chemistry，2008年10月01日，Vol. 46, No. 19，pp. 6393-6406，DOI: 10.1002/pola.22940

Also Published As

Publication number Publication date
AU2019294819B2 (en) 2025-04-03
US20210267909A1 (en) 2021-09-02
CN113226468B (zh) 2025-03-25
EP3813948A1 (en) 2021-05-05
WO2020006224A1 (en) 2020-01-02
US20240366529A1 (en) 2024-11-07
AU2019294819A1 (en) 2021-02-18
US12274679B2 (en) 2025-04-15
CN113226468A (zh) 2021-08-06
CA3145096A1 (en) 2020-01-02
US11684590B2 (en) 2023-06-27
JP2021529778A (ja) 2021-11-04

Similar Documents

Publication Publication Date Title
US12274679B2 (en) Substituted alkylphenols as HCN1 antagonists
US20240269093A1 (en) Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders
JP7785108B2 (ja) 血漿カリクレインの阻害剤およびその使用
JP2016511744A (ja) Ｐｒｍｔ５を阻害する方法
WO2012006104A2 (en) Compounds and methods for treating tuberculosis infection
US20230167081A1 (en) 5-amino-2-piperidinon-3-yl-1-oxoisoindoline derivatives for degradation of ikzf2 degraders
JP2019505548A (ja) Ｍｙｃモジュレーターとしてのｍａｘバインダーおよびこれらの使用
WO2024233839A1 (en) Small molecule inhibitors of glutaminase
US20240417372A1 (en) Esters of a retinoid and bakuchiol and preparations thereof
KR20220119648A (ko) 히알루론산 유도체
WO2024086705A2 (en) Bicyclic enhancers of the particulate guanylyl cyclase receptor a
US9550744B2 (en) Vitamin C prodrugs and uses thereof
EP3947382B1 (en) Compounds for uses in pharmacological induction of hbf for treatment of sickle cell disease and beta-thalassemia
WO2024086717A2 (en) Heteroaryl enhancers of the particulate guanylyl cyclase receptor a
WO2025024605A1 (en) Rev-erb antagonists
WO2025075976A2 (en) Methyl-branched liposomes for sustained drug delivery
KR20250129803A (ko) Pparg 조정제
US20230095276A1 (en) Esters of a retinoid and a tocopherol or tert-butylhydroquinone and preparations thereof
WO2025024550A1 (en) Rev-erb antagonists

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220621

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220621

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230620

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230919

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240130

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240425

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240730

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240925

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241025

R150 Certificate of patent or registration of utility model

Ref document number: 7583438

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150